Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI

Bon-Kwon Koo1, Xinyang Hu1, Jeehoon Kang1

  • 1From Seoul National University Hospital (B.-K.K., J.K., D.H., H.-S.K.), Samsung Medical Center (J.-Y.H., J.-M.L.), and Kyung Hee University Hospital (W.K.), Seoul, Keimyung University Dongsan Medical Center (C.-W.N.) and Yeungnam University Medical Center (U.K.), Daegu, Inje University Ilsan Paik Hospital, Goyang (J.-H.D.), Kangwon National University Hospital, Chuncheon (B.-K.L.), Wonju Severance Christian Hospital, Wonju (S.-G.A.), Ajou University Hospital, Suwon (M.-H.Y., S.-J.T.), Uijeongbu Eulji Medical Center, Uijeongbu (Y-.J.K.), and Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan (E.-S.S.) - all in South Korea; the Second Affiliated Hospital, Zhejiang University School of Medicine (X.H., J.Z., J.J., J.W.), Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine (J.H.), Hangzhou Normal University Affiliated Hospital (F.J.), and Zhejiang Hospital (L.T.), Hangzhou, the First Affiliated Hospital of Wenzhou Medical University (H.Z.), the Second Affiliated Hospital of Wenzhou Medical University (P.C.), and the Third Clinical Institute Affiliated to Wenzhou Medical University (W.J.), Wenzhou, and Ningbo First Hospital (X.C.) and the Affiliated Hospital of the Medical School of Ningbo University (W.H.), Ningbo - all in China.

Insights

Fractional flow reserve (FFR) guidance is as effective as intravascular ultrasonography (IVUS) guidance for patients undergoing percutaneous coronary intervention (PCI). Both methods showed similar rates of death, heart attack, or revascularization at 24 months.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Percutaneous coronary intervention (PCI) decisions for coronary artery disease often use fractional flow reserve (FFR) or intravascular ultrasonography (IVUS).
  • The comparative clinical outcomes of using only FFR or IVUS for both PCI decision-making and stent assessment remain unclear.

Purpose of the Study:

  • To compare the clinical outcomes of FFR-guided versus IVUS-guided PCI in patients with intermediate coronary artery stenosis.
  • To determine if FFR guidance is noninferior to IVUS guidance for key adverse cardiovascular events.

Main Methods:

  • A randomized trial involving 1682 patients with intermediate coronary stenosis undergoing evaluation for PCI.
  • Patients were assigned to either FFR-guided or IVUS-guided procedures, with specific criteria for PCI based on FFR values (≤0.80) or IVUS measurements (minimal lumen area ≤3 mm² or 3-4 mm² with >70% plaque burden).
  • The primary outcome was a composite of death, myocardial infarction, or revascularization at 24 months, with noninferiority testing for the FFR group compared to the IVUS group.

Main Results:

  • PCI was performed in 44.4% of patients in the FFR group and 65.3% in the IVUS group.
  • At 24 months, the primary outcome occurred in 8.1% of the FFR group and 8.5% of the IVUS group, demonstrating noninferiority (absolute difference -0.4%, upper 97.5% CI 2.2%, P=0.01).
  • Patient-reported outcomes, assessed by the Seattle Angina Questionnaire, were similar between the two groups.

Conclusions:

  • FFR guidance is noninferior to IVUS guidance for managing patients with intermediate coronary stenosis undergoing PCI.
  • The study supports the use of FFR as a primary guidance tool for PCI, yielding comparable clinical outcomes to IVUS.
  • Both FFR and IVUS are effective in guiding PCI decisions, but FFR resulted in lower rates of the intervention itself.
Abstract